2439 related articles for article (PubMed ID: 22286061)
41. Single cell analysis of RNA-mediated histone H3.3 recruitment to a cytomegalovirus promoter-regulated transcription site.
Newhart A; Rafalska-Metcalf IU; Yang T; Joo LM; Powers SL; Kossenkov AV; Lopez-Jones M; Singer RH; Showe LC; Skordalakes E; Janicki SM
J Biol Chem; 2013 Jul; 288(27):19882-99. PubMed ID: 23689370
[TBL] [Abstract][Full Text] [Related]
42. Compromised Telomeric Heterochromatin Promotes ALTernative Lengthening of Telomeres.
Voon HPJ; Collas P; Wong LH
Trends Cancer; 2016 Mar; 2(3):114-116. PubMed ID: 28741530
[TBL] [Abstract][Full Text] [Related]
43. The chromatin remodeller ATRX facilitates diverse nuclear processes, in a stochastic manner, in both heterochromatin and euchromatin.
Truch J; Downes DJ; Scott C; Gür ER; Telenius JM; Repapi E; Schwessinger R; Gosden M; Brown JM; Taylor S; Cheong PL; Hughes JR; Higgs DR; Gibbons RJ
Nat Commun; 2022 Jun; 13(1):3485. PubMed ID: 35710802
[TBL] [Abstract][Full Text] [Related]
44. New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M.
Karsy M; Guan J; Cohen AL; Jensen RL; Colman H
Curr Neurol Neurosci Rep; 2017 Feb; 17(2):19. PubMed ID: 28271343
[TBL] [Abstract][Full Text] [Related]
45. Suppression of the alternative lengthening of telomere pathway by the chromatin remodelling factor ATRX.
Clynes D; Jelinska C; Xella B; Ayyub H; Scott C; Mitson M; Taylor S; Higgs DR; Gibbons RJ
Nat Commun; 2015 Jul; 6():7538. PubMed ID: 26143912
[TBL] [Abstract][Full Text] [Related]
46. The PML-associated protein DEK regulates the balance of H3.3 loading on chromatin and is important for telomere integrity.
Ivanauskiene K; Delbarre E; McGhie JD; Küntziger T; Wong LH; Collas P
Genome Res; 2014 Oct; 24(10):1584-94. PubMed ID: 25049225
[TBL] [Abstract][Full Text] [Related]
47. PML is recruited to heterochromatin during S phase and represses DAXX-mediated histone H3.3 chromatin assembly.
Shastrula PK; Sierra I; Deng Z; Keeney F; Hayden JE; Lieberman PM; Janicki SM
J Cell Sci; 2019 Mar; 132(6):. PubMed ID: 30796101
[TBL] [Abstract][Full Text] [Related]
48. A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas.
Venneti S; Santi M; Felicella MM; Yarilin D; Phillips JJ; Sullivan LM; Martinez D; Perry A; Lewis PW; Thompson CB; Judkins AR
Acta Neuropathol; 2014 Nov; 128(5):743-53. PubMed ID: 25200322
[TBL] [Abstract][Full Text] [Related]
49. Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma.
Kannan K; Inagaki A; Silber J; Gorovets D; Zhang J; Kastenhuber ER; Heguy A; Petrini JH; Chan TA; Huse JT
Oncotarget; 2012 Oct; 3(10):1194-203. PubMed ID: 23104868
[TBL] [Abstract][Full Text] [Related]
50. H3F3A K27M mutations in thalamic gliomas from young adult patients.
Aihara K; Mukasa A; Gotoh K; Saito K; Nagae G; Tsuji S; Tatsuno K; Yamamoto S; Takayanagi S; Narita Y; Shibui S; Aburatani H; Saito N
Neuro Oncol; 2014 Jan; 16(1):140-6. PubMed ID: 24285547
[TBL] [Abstract][Full Text] [Related]
51. ATRX and the replication of structured DNA.
Clynes D; Gibbons RJ
Curr Opin Genet Dev; 2013 Jun; 23(3):289-94. PubMed ID: 23453691
[TBL] [Abstract][Full Text] [Related]
52. Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas.
Lee JC; Jeng YM; Liau JY; Tsai JH; Hsu HH; Yang CY
Mod Pathol; 2015 Aug; 28(8):1064-73. PubMed ID: 26022452
[TBL] [Abstract][Full Text] [Related]
53. Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.
Marinoni I; Kurrer AS; Vassella E; Dettmer M; Rudolph T; Banz V; Hunger F; Pasquinelli S; Speel EJ; Perren A
Gastroenterology; 2014 Feb; 146(2):453-60.e5. PubMed ID: 24148618
[TBL] [Abstract][Full Text] [Related]
54. Emerging roles of ATRX in cancer.
Watson LA; Goldberg H; Bérubé NG
Epigenomics; 2015; 7(8):1365-78. PubMed ID: 26646632
[TBL] [Abstract][Full Text] [Related]
55. Comprehensive screening of alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas.
Liau JY; Lee JC; Tsai JH; Yang CY; Liu TL; Ke ZL; Hsu HH; Jeng YM
Mod Pathol; 2015 Dec; 28(12):1545-54. PubMed ID: 26428317
[TBL] [Abstract][Full Text] [Related]
56. PML protein organizes heterochromatin domains where it regulates histone H3.3 deposition by ATRX/DAXX.
Delbarre E; Ivanauskiene K; Spirkoski J; Shah A; Vekterud K; Moskaug JØ; Bøe SO; Wong LH; Küntziger T; Collas P
Genome Res; 2017 Jun; 27(6):913-921. PubMed ID: 28341773
[TBL] [Abstract][Full Text] [Related]
57. The Daxx/Atrx Complex Protects Tandem Repetitive Elements during DNA Hypomethylation by Promoting H3K9 Trimethylation.
He Q; Kim H; Huang R; Lu W; Tang M; Shi F; Yang D; Zhang X; Huang J; Liu D; Songyang Z
Cell Stem Cell; 2015 Sep; 17(3):273-86. PubMed ID: 26340527
[TBL] [Abstract][Full Text] [Related]
58. Clinical features of ATRX or DAXX mutated neuroblastoma.
Kurihara S; Hiyama E; Onitake Y; Yamaoka E; Hiyama K
J Pediatr Surg; 2014 Dec; 49(12):1835-8. PubMed ID: 25487495
[TBL] [Abstract][Full Text] [Related]
59. Alternative lengthening of telomeres, ATRX loss and H3-K27M mutations in histologically defined pilocytic astrocytoma with anaplasia.
Rodriguez FJ; Brosnan-Cashman JA; Allen SJ; Vizcaino MA; Giannini C; Camelo-Piragua S; Webb M; Matsushita M; Wadhwani N; Tabbarah A; Hamideh D; Jiang L; Chen L; Arvanitis LD; Alnajar HH; Barber JR; Rodríguez-Velasco A; Orr B; Heaphy CM
Brain Pathol; 2019 Jan; 29(1):126-140. PubMed ID: 30192422
[TBL] [Abstract][Full Text] [Related]
60. A glioblastoma neurosphere line with alternative lengthening of telomeres.
Heaphy CM; Schreck KC; Raabe E; Mao XG; An P; Chu Q; Poh W; Jiao Y; Rodriguez FJ; Odia Y; Meeker AK; Eberhart CG
Acta Neuropathol; 2013 Oct; 126(4):607-8. PubMed ID: 24022427
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
